ABBOTT LABORATORIES (1ABT.MI) Fundamental Analysis & Valuation

BIT:1ABT • US0028241000

Current stock price

91.14 EUR
-2.79 (-2.97%)
Last:

This 1ABT.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1ABT.MI Profitability Analysis

1.1 Basic Checks

  • 1ABT had positive earnings in the past year.
  • In the past year 1ABT had a positive cash flow from operations.
  • In the past 5 years 1ABT has always been profitable.
  • In the past 5 years 1ABT always reported a positive cash flow from operatings.
1ABT.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.52%, 1ABT belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
  • 1ABT has a Return On Equity of 12.51%. This is in the better half of the industry: 1ABT outperforms 79.03% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.17%, 1ABT is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for 1ABT is in line with the industry average of 10.01%.
  • The last Return On Invested Capital (9.17%) for 1ABT is above the 3 year average (8.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROIC 9.17%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1ABT.MI Yearly ROA, ROE, ROIC1ABT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 14.72%, 1ABT belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
  • In the last couple of years the Profit Margin of 1ABT has grown nicely.
  • 1ABT's Operating Margin of 18.85% is fine compared to the rest of the industry. 1ABT outperforms 77.42% of its industry peers.
  • In the last couple of years the Operating Margin of 1ABT has grown nicely.
  • 1ABT has a Gross Margin (56.68%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of 1ABT has remained more or less at the same level.
Industry RankSector Rank
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
1ABT.MI Yearly Profit, Operating, Gross Margins1ABT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. 1ABT.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 1ABT is destroying value.
  • 1ABT has more shares outstanding than it did 1 year ago.
  • 1ABT has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1ABT has an improved debt to assets ratio.
1ABT.MI Yearly Shares Outstanding1ABT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
1ABT.MI Yearly Total Debt VS Total Assets1ABT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

  • 1ABT has an Altman-Z score of 4.93. This indicates that 1ABT is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.93, 1ABT belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
  • 1ABT has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1ABT (1.75) is better than 80.65% of its industry peers.
  • 1ABT has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of 1ABT (0.19) is better than 70.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Altman-Z 4.93
ROIC/WACC0.87
WACC10.48%
1ABT.MI Yearly LT Debt VS Equity VS FCF1ABT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

2.3 Liquidity

  • A Current Ratio of 1.58 indicates that 1ABT should not have too much problems paying its short term obligations.
  • The Current ratio of 1ABT (1.58) is comparable to the rest of the industry.
  • A Quick Ratio of 1.18 indicates that 1ABT should not have too much problems paying its short term obligations.
  • 1ABT has a Quick ratio (1.18) which is comparable to the rest of the industry.
  • The current and quick ratio evaluation for 1ABT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.18
1ABT.MI Yearly Current Assets VS Current Liabilites1ABT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. 1ABT.MI Growth Analysis

3.1 Past

  • 1ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
  • The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
  • 1ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
  • Measured over the past years, 1ABT shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%

3.2 Future

  • Based on estimates for the next years, 1ABT will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
  • Based on estimates for the next years, 1ABT will show a small growth in Revenue. The Revenue will grow by 7.06% on average per year.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ABT.MI Yearly Revenue VS Estimates1ABT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1ABT.MI Yearly EPS VS Estimates1ABT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. 1ABT.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 20.39, the valuation of 1ABT can be described as rather expensive.
  • 1ABT's Price/Earnings ratio is a bit cheaper when compared to the industry. 1ABT is cheaper than 74.19% of the companies in the same industry.
  • 1ABT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 18.27, which indicates a rather expensive current valuation of 1ABT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABT is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. 1ABT is around the same levels.
Industry RankSector Rank
PE 20.39
Fwd PE 18.27
1ABT.MI Price Earnings VS Forward Price Earnings1ABT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABT is on the same level as its industry peers.
  • 1ABT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 24.66
EV/EBITDA 16.21
1ABT.MI Per share data1ABT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of 1ABT may justify a higher PE ratio.
PEG (NY)1.77
PEG (5Y)2.86
EPS Next 2Y10.76%
EPS Next 3Y10.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. 1ABT.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.41%, 1ABT has a reasonable but not impressive dividend return.
  • 1ABT's Dividend Yield is a higher than the industry average which is at 1.21.
  • Compared to an average S&P500 Dividend Yield of 1.89, 1ABT pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.41%

5.2 History

  • The dividend of 1ABT is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1ABT pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
  • 1ABT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
1ABT.MI Yearly Income VS Free CF VS Dividend1ABT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
1ABT.MI Dividend Payout.1ABT.MI Dividend Payout, showing the Payout Ratio.1ABT.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1ABT.MI Fundamentals: All Metrics, Ratios and Statistics

ABBOTT LABORATORIES

BIT:1ABT (3/27/2026, 7:00:00 PM)

91.14

-2.79 (-2.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-14
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap158.37B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target114.43 (25.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.41%
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)-1.65%
PT rev (3m)-9.54%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-4.38%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-2%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 20.39
Fwd PE 18.27
P/S 4.11
P/FCF 24.66
P/OCF 19.07
P/B 3.5
P/tB 8.08
EV/EBITDA 16.21
EPS(TTM)4.47
EY4.9%
EPS(NY)4.99
Fwd EY5.47%
FCF(TTM)3.7
FCFY4.05%
OCF(TTM)4.78
OCFY5.24%
SpS22.15
BVpS26.05
TBVpS11.28
PEG (NY)1.77
PEG (5Y)2.86
Graham Number51.18
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 12.51%
ROCE 11.9%
ROIC 9.17%
ROICexc 10.51%
ROICexgc 20.3%
OM 18.85%
PM (TTM) 14.72%
GM 56.68%
FCFM 16.68%
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.75
Debt/EBITDA 0.86
Cap/Depr 69.67%
Cap/Sales 4.9%
Interest Coverage 15.33
Cash Conversion 83.39%
Profit Quality 113.35%
Current Ratio 1.58
Quick Ratio 1.18
Altman-Z 4.93
F-Score6
WACC10.48%
ROIC/WACC0.87
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%

ABBOTT LABORATORIES / 1ABT.MI Fundamental Analysis FAQ

What is the fundamental rating for 1ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1ABT.MI.


What is the valuation status for 1ABT stock?

ChartMill assigns a valuation rating of 3 / 10 to ABBOTT LABORATORIES (1ABT.MI). This can be considered as Overvalued.


Can you provide the profitability details for ABBOTT LABORATORIES?

ABBOTT LABORATORIES (1ABT.MI) has a profitability rating of 8 / 10.


What is the financial health of ABBOTT LABORATORIES (1ABT.MI) stock?

The financial health rating of ABBOTT LABORATORIES (1ABT.MI) is 8 / 10.


What is the earnings growth outlook for ABBOTT LABORATORIES?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (1ABT.MI) is expected to grow by 11.53% in the next year.